在小鼠模型中,YKL-40通过诱导免疫细胞透来抑制黑色素瘤的进展和转移

Hailong Zhang1,2, Xiangyu Zhao1, Mengqi Shi1,3

  • 1School of Life Science and Technology, Shandong Second Medical University, 7166 Baotong Street, Weifang, 261053, Shandong, People's Republic of China.

Scientific reports
|March 3, 2025
PubMed
概括

糖蛋白YKL-40在黑色素瘤中显示出潜在的瘤抑制作用. 它的过度表达减少了黑色素瘤细胞的生长和转移,这表明它在调节免疫疗法的瘤免疫相互作用方面发挥了作用.